The remaining authors declare the research was carried out from the absence of any commercial or economic associations which could be construed as a potential conflict of interest. Inhibition of galectin-3 with GB1211 was not connected to any remedy- or dose-similar developments and there were no clinically considerable security or https://selvigaltin-gb121167999.blogthisbiz.com/46674021/the-ultimate-guide-to-gb1211